By David Harlow – The recent Executive Order regarding health care price transparency has many folks in the health care industrial complex contemplating litigation aimed at highlighting ways in which the order may contravene existing law.
Read More
Harlow on Healthcare episode NOW on Demand. Host David Harlow talks with Jeanne Pinder, founder and CEO of Clear Health Costs on transparency and consumer empowerment.
By David Harlow JD MPH – Much has been said about cost transparency in healthcare, and recently, the administration got slightly more specific, issuing an Executive Order calling for some regulations and reports:
By David Harlow – Vibrent, one of NIH’s data management contractor for the All of Us genomic and other health data research project, was found by OIG to have a number of holes in its data security infrastructure and policies, ranging from…
By David Harlow – Recently, a federal court found the administration’s 340B program rates to be fatally flawed; the HHS Secretary “patently violated” the governing law.
By David Harlow – Recently, th OCR has released two new issuances touching on HIPAA interpretation and enforcement. On the one hand, the regulated community eagerly awaits and devours these morsels as they are doled out.
Harlow on Healthcare episode NOW on Demand. Host David Harlow talks with James Grana PhD, Chief Analytics Officer of Rush Health – a four-hospital, 1500-provider clinically-integrated network in Chicago.
By David Harlow – The U.S. healthcare system is on a journey – a journey to the future. When we get there, we need to be sure that environmental conditions are right; if they are not, the system — and possibly all of the system’s patients — will be at grave risk.
Understanding how a person’s genetics, environment, and lifestyle can help determine the best approach to prevent or treat disease. We are on the beat to find and report just what is happening now in Precision Medicine which includes Royal Philips, Miami Cancer Institute, Jintel Health, All of Us Research Program, & more.